Treatment for Low Iron Levels
Start ferrous sulfate 200 mg once daily in the morning on an empty stomach as first-line treatment for iron deficiency. 1
First-Line Oral Iron Therapy
Ferrous sulfate 200 mg once daily is the preferred regimen due to superior tolerability and effectiveness compared to multiple daily dosing, while remaining the most cost-effective option. 2, 1 This represents a shift from older recommendations of divided doses throughout the day. 2
Dosing Strategy
- Take as a single morning dose rather than divided throughout the day 1
- Administer on an empty stomach for optimal absorption, though taking with food is acceptable if gastrointestinal side effects occur 1
- Add vitamin C (ascorbic acid) 500 mg with each iron dose to enhance absorption, particularly when response is suboptimal 2, 1
- Alternate-day dosing may be considered for doses ≥60 mg to maximize fractional iron absorption and reduce side effects 3
Expected Response and Treatment Duration
- Hemoglobin should rise by approximately 2 g/dL after 3-4 weeks of treatment 2, 1
- Continue oral iron for 3 months after anemia correction to fully replenish iron stores 2, 1
- If no hemoglobin rise occurs within 4 weeks, assess for non-adherence, ongoing blood loss, malabsorption, or misdiagnosis 2, 1
When to Use Intravenous Iron Instead
Switch to IV iron as first-line therapy in the following situations:
- Clinically active inflammatory bowel disease 1
- Hemoglobin <10 g/dL 1
- Previous oral iron intolerance (failed at least two oral preparations) 2, 1
- Malabsorption syndromes including celiac disease or post-bariatric surgery 1
- Chronic inflammatory conditions such as chronic kidney disease, heart failure, or cancer 4
- Second and third trimesters of pregnancy when rapid correction is needed 4
- Ongoing blood loss exceeding intestinal absorption capacity 5
Monitoring Schedule
- Check hemoglobin and red cell indices at 3-month intervals for the first year 2, 1
- Recheck after another year 2, 1
- Provide additional iron supplementation if hemoglobin or MCV falls below normal 2, 1
Special Population Considerations
Pregnant Women
- Start 30 mg/day at first prenatal visit for primary prevention 2
- Increase to 60-120 mg/day for treatment of anemia 2, 1
- Decrease to 30 mg/day when hemoglobin normalizes for gestational stage 2, 1
- Refer to specialist if hemoglobin <9.0 g/dL or hematocrit <27.0% 2, 1
Inflammatory Bowel Disease
- Treat active inflammation first to enhance iron absorption and reduce iron depletion 1
- Use IV iron as first-line in clinically active disease 1
Post-Bariatric Surgery
- Prefer IV iron due to disrupted duodenal absorption mechanisms 1
Critical Pitfalls to Avoid
- Do not prescribe multiple daily doses – once-daily or alternate-day dosing improves tolerability with similar or better efficacy 1, 3
- Do not stop iron when hemoglobin normalizes – continue for 3 months to replenish stores 2, 1
- Do not continue oral iron indefinitely without response – reassess after 4 weeks and switch to IV iron if hemoglobin fails to rise 2, 1
- Do not overlook vitamin C supplementation when oral iron response is suboptimal 2, 1
- Do not use parenteral iron routinely – reserve for specific indications as it is painful, expensive, and carries anaphylaxis risk 2
Investigation of Underlying Cause
While treating with iron supplementation, identify and address the underlying cause of iron deficiency:
- Patients >45 years: Investigate with bidirectional endoscopy (upper GI endoscopy with small bowel biopsy and colonoscopy) due to increasing incidence of significant pathology with age 2, 1
- Patients <45 years: Perform endoscopy only if upper GI symptoms present; otherwise test antiendomysial antibodies to exclude celiac disease 2, 1
- Menstruating women: Consider menorrhagia as primary cause, though those >45 years should still undergo GI investigation 2
Treatment Failure Management
If anemia does not resolve within 6 months despite appropriate iron therapy:
- Reassess for ongoing blood loss, malabsorption syndromes, non-adherence, or misdiagnosis 2, 1
- Consider further gastrointestinal investigation with small bowel evaluation 1
- Consider hematology consultation for complex cases 1
- Further evaluate with MCV, RDW, and serum ferritin if no response after 4 weeks 2
- Consider thalassemia minor or sickle cell trait in women of African, Mediterranean, or Southeast Asian ancestry with mild anemia unresponsive to iron therapy 2